Cargando…
PRMT1 loss sensitizes cells to PRMT5 inhibition
PRMT5 is an arginine methyltransferase that accounts for the vast majority of the symmetric methylation in cells. PRMT5 exerts its function when complexed with MEP50/WDR77. This activity is often elevated in cancer cells and correlates with poor prognosis, making PRMT5 a therapeutic target. To inves...
Autores principales: | Gao, Guozhen, Zhang, Liang, Villarreal, Oscar D, He, Wei, Su, Dan, Bedford, Ella, Moh, Phoebe, Shen, Jianjun, Shi, Xiaobing, Bedford, Mark T, Xu, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547413/ https://www.ncbi.nlm.nih.gov/pubmed/30916320 http://dx.doi.org/10.1093/nar/gkz200 |
Ejemplares similares
-
PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1
por: Gao, Guozhen, et al.
Publicado: (2017) -
A gain-of-function mouse model identifies PRMT6 as a NF-κB coactivator
por: Di Lorenzo, Alessandra, et al.
Publicado: (2014) -
The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4
por: Mallappa, Chandrashekara, et al.
Publicado: (2011) -
Klf4 methylated by Prmt1 restrains the commitment of primitive endoderm
por: Zuo, Zhen-yu, et al.
Publicado: (2022) -
A feedback regulatory loop between methyltransferase PRMT1 and orphan receptor TR3
por: Lei, Na-zi, et al.
Publicado: (2009)